Health Care Stocks Dominate Intraday Session with Impressive Gains and Losses

Impressive Gains in Health Care Stocks

Several health care stocks made waves during Thursday's intraday session, showcasing their domination in the market. Sigilon Therapeutics (SGTX) emerged as a powerhouse, with its shares skyrocketing by an astounding 506.6% to $23.84. Immunome (IMNM) followed suit, experiencing an impressive 33.67% increase to $7.9. Kintara Therapeutics (KTRA) also saw significant gains, with shares moving upwards by 28.94% to $3.86.

Trxade Health (MEDS) demonstrated its success, with shares climbing by 22.97% to $13.22. Adamis Pharmaceuticals (ADMP) also experienced a notable increase of 22.0% to $2.55. Inovio Pharmaceuticals (INO) rounded out the list of gainers, with shares rising by 18.21% to $0.46.

These stocks showcased the power and potential of the health care sector, enticing investors with their impressive performance. Their significant gains reflect the innovation and growth within the industry, making them attractive prospects for those seeking investment opportunities.

Trading volumes for these gainers varied, with Sigilon Therapeutics leading the pack at 53000.3% of its average full-day volume over the last 100 days. Immunome followed closely behind at 36175.8%, while Kintara Therapeutics and Adamis Pharmaceuticals had trading volumes of 1584.9% and 120.5% respectively. Trxade Health and Inovio Pharmaceuticals also experienced notable trading volumes of 47.2% and 119.2% of their average full-day volumes over the last 100 days.

Investors should keep a close eye on these health care stocks as they continue to dominate the market, showcasing their potential for success and growth.

Health Care Stocks Experience Mixed Fortunes

While some health care stocks saw impressive gains, others faced losses during Thursday's intraday session. BioXcel Therapeutics (BTAI) experienced a decline of 65.8% to $6.04, showcasing the volatility and unpredictability of the market. Cormedix (CRMD) also faced a downturn, with its stock declining by 21.21% to $4.0.

Liquidia (LQDA) and ATI Physical Therapy (ATIP) also experienced losses, with their shares decreasing by 19.05% to $8.02 and 18.34% to $8.46 respectively. Lumos Pharma (LUMO) and Sientra (SIEN) rounded out the list of losers, with shares declining by 17.4% to $3.23 and 16.31% to $2.69 respectively.

Despite these losses, it's important to note that the health care sector is known for its volatility, and occasional dips are to be expected. Investors should approach these stocks with caution and consider the wider market conditions before making any decisions.

Trading volumes for these losers varied, with BioXcel Therapeutics experiencing a trading volume of 3263.7% of its average full-day volume over the last 100 days. Cormedix had a trading volume of 645.3%, while Liquidia and ATI Physical Therapy saw trading volumes of 511.4% and 317.3% respectively. Sientra had a slightly lower trading volume of 88.5%.

As the health care sector continues to evolve, it's crucial for investors to stay informed about the performance of these stocks and to carefully evaluate their potential for future growth and recovery.


Benzinga Insights. (June 29, 2023). 12 Health Care Stocks Moving In Thursday's Intraday Session. (Jeremy Bowman). (June 29, 2023). Why LTL Stocks Were Surging This Week.

Content Restricted To Members